<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">

Culture Clash - Autologous versus Allogeneic Cells in Oncology

Aug 11, 2022 11:30:00 AM / by Champions Oncology posted in Hematological Malignancies, Ex Vivo Platforms

Adoptive cell therapies (ACTs) are being broadly tested and implemented in the treatment of a wide range of cancers, but the success of these therapies has been limited by the challenges of expanding cells of interest ex vivo. Most studies collect peripheral blood cells from a patient and expand, enrich or modify tumor-specific cells in a laboratory environment to create a blood product with tumor-targeting cells that can be reinfused into the patient.

Read More →